Evidence map›Paper›PMID 39334295›Full record

ArticleBMC medical informatics and decision making2024

Late feature fusion using neural network with voting classifier for Parkinson's disease detection.

Abeer Aljohani

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abeer AljohaniDepartment of Computer Science and Informatics, Taibah University, Medina, 42353, Saudi Arabia. aahjohani@taibahu.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is classified as a neurological, progressive illness brought on by cell death in the posterior midbrain. Early PD detection will assist doctors in reducing the disease's consequences. A collection of skilled models that may be applied to regression as well as classification is known as artificial intelligence (AI). PD can be detected using a variety of dataset formats, including text, speech, and picture datasets. For the purpose of classifying Parkinson's disease, this study suggests merging deep with machine learning recognition approaches. The three primary components of the suggested approach are designed to enhance the accuracy of Parkinson's disease early diagnosis. These sections cover the topics of categorising, combining, and separating. Convolutional Neural Networks (CNN) as well as attention procedures are used to create feature extractors. The related motion signals are fed to a combination of convolutional neural network and long-short-memory model for feature extraction. Besides, for the classification of patients from non-suffers of Parkinson's disease, Random Forest, Logistic Regression, Support Vector Machine, Extreme Boot Classifier, and voting classifier were used. Our result shows that for the PD handwriting and related motion datasets, using the proposed CNN with an attention and voting classifier yields 99.95% accuracy, 99.99% precision, 99.98% sensitivity, and 99.95% F1-score. Based on these results, it is warranted to conclude that the proposed methodology of feature extraction from photos of handwriting and relating motor symptoms, fusing of those features, and following it with a voting classifier yields excellent results for PD classification.

Indexed as

Neural Networks, ComputerParkinson DiseaseEarly DiagnosisHandwritingHumansMachine LearningVotingAttention mechanismFusionMachine learningParkinson’s diseaseVoting classifier

Identifiers

PMID39334295
PMCPMC11429630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.